Intelligent Bio Solutions Secures Eighth European Patent for Advanced Fingerprint Drug Testing Technology
核心洞察
Intelligent Bio Solutions received European Patent EP3752831 for contextualizing fingerprint chemical analysis with fingerprint deposition volume, marking the company's eighth European patent.
The patented technology improves substance interpretation by correlating chemical findings with fingerprint residue volume, strengthening the robustness of the testing process.
The company's fingerprint sweat drug testing system screens for opiates (搜索), cocaine, methamphetamine, and cannabis with sample collection in seconds and results in under ten minutes.
Intelligent Bio Solutions Inc. (Nasdaq: INBS) announced on March 26, 2026, that it has received European Patent EP3752831, related to contextualizing fingerprint chemical analysis with fingerprint deposition volume. This marks the company's eighth European patent, further strengthening its intellectual property portfolio around fingerprint sweat drug testing technology.
Patent Innovation Enhances Testing Accuracy
The newly granted patent protects a key advancement in how the company's technology analyzes substances detected in fingerprint sweat by correlating chemical findings with the volume of fingerprint residue deposited during sample collection. By contextualizing chemical analysis with deposition volume, the technology improves the interpretation of detected substances and strengthens the robustness of the testing process.
This innovation adds another layer of sophistication to INBS' testing methodology. The company's growing European IP portfolio now encompasses multiple aspects of its screening system, including lateral flow fingerprint analysis, sample collection cartridges, and lateral flow test strip reader.
Market Position and Technology Advantages
"The grant of our eighth European patent reflects the depth of innovation embedded in our fingerprint sweat drug testing technology," said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. "Each patent we secure reinforces our market position and protects the scientific breakthroughs that make our non-invasive approach a compelling alternative to traditional drug screening methods."
INBS' Intelligent Fingerprinting Drug Testing Solution offers organizations across safety-critical sectors a faster, more dignified alternative to conventional testing methods. By analyzing fingerprint sweat for the presence of common substances of abuse, the technology eliminates many of the logistical and privacy concerns associated with traditional sample collection while delivering rapid, reliable results.
Technology Specifications and Applications
The company's Intelligent Fingerprinting Drug Screening System screens for the recent use of drugs commonly found in the workplace, including opiates (搜索), cocaine, methamphetamine, and cannabis. The system is designed as a hygienic and cost-effective solution with sample collection in seconds and results in under ten minutes.
The technology serves as a valuable tool for employers in safety-critical industries. The company's current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
Future Applications and Market Potential
Intelligent Bio Solutions believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields beyond workplace drug screening.